Literature DB >> 34238028

Shockwave Treatment Enhanced Extracellular Matrix Production in Articular Chondrocytes Through Activation of the ROS/MAPK/Nrf2 Signaling Pathway.

Po-Chih Shen1,2, Shih-Hsiang Chou1, Cheng-Chang Lu1,2,3, Hsuan-Ti Huang1,4, Song-Hsiung Chien1, Peng-Ju Huang1, Zi-Miao Liu1, Chia-Lung Shih1, Shu-Jem Su5, Li-Min Chen6, Yin-Chun Tien1,2.   

Abstract

OBJECTIVE: Shockwave application is a potential treatment for osteoarthritis (OA), but the underlying mechanism remains unknown. Oxidative stress and a counterbalancing antioxidant system might be the key to understanding this mechanism. We hypothesized that reactive oxygen species (ROS) and the transcription factor nuclear factor erythroid 2-related factor 2 (Nrf2),which is an important regulator of cellular redox homeostasis, are plausible elements.
DESIGN: Porcine chondrocytes were cultured in a 3-dimensional pellet model and subjected to shockwaves. The effects of shockwaves with various energy-flux densities on optimal extracellular matrix (ECM) synthesis were assessed. ROS, mitogen-activated protein kinase (MAPK) signaling, and the redox activity of Nrf2 were measured. To investigate the signaling mechanism involved in the shockwave treatment in chondrocytes, specific inhibitors of ROS, MAPK signaling, and Nrf2 activity were targeted.
RESULTS: Shockwaves increased ECM synthesis without affecting cell viability or proliferation. Furthermore, they induced transient ROS production mainly through xanthine oxidase. The phosphorylation of ERK1/2 and p38 and the nuclear translocation of Nrf2 were activated by shockwaves. By contrast, suppression of ROS signaling mitigated shockwave-induced MAPK phosphorylation, Nrf2 nuclear translocation, and ECM synthesis. Pretreatment of chondrocytes with the specific inhibitors of MEK1/2 and p38, respectively, mitigated the shockwave-induced nuclear translocation of Nrf2 and ECM synthesis. Nrf2 inhibition by both small hairpin RNA knockdown and brusatol reduced the shockwave-enhanced ECM synthesis.
CONCLUSIONS: Shockwaves activated Nrf2 activity through the induction of transient ROS signaling and subsequently enhanced ECM synthesis in chondrocytes. This study provided fundamental evidence confirming the potential of shockwaves for OA management.

Entities:  

Keywords:  Nrf2; chondrocyte; osteoarthritis; reactive oxygen species; shockwave

Mesh:

Substances:

Year:  2021        PMID: 34238028      PMCID: PMC8804851          DOI: 10.1177/19476035211012465

Source DB:  PubMed          Journal:  Cartilage        ISSN: 1947-6035            Impact factor:   3.117


  54 in total

1.  Effects of extracorporeal shock waves on human articular chondrocytes and ovine bone marrow stromal cells in vitro.

Authors:  R Dorotka; B Kubista; K-D Schatz; K Trieb
Journal:  Arch Orthop Trauma Surg       Date:  2003-07-05       Impact factor: 3.067

2.  Nuclear factor E2 p45-related factor 2 negatively regulates chondrogenesis.

Authors:  Eiichi Hinoi; Takeshi Takarada; Sayumi Fujimori; Liyang Wang; Mika Iemata; Kyosuke Uno; Yukio Yoneda
Journal:  Bone       Date:  2006-10-06       Impact factor: 4.398

3.  Superoxide mediates shock wave induction of ERK-dependent osteogenic transcription factor (CBFA1) and mesenchymal cell differentiation toward osteoprogenitors.

Authors:  Feng-Sheng Wang; Ching-Jen Wang; Shyr-Ming Sheen-Chen; Yur-Ren Kuo; Rong-Fu Chen; Kuender D Yang
Journal:  J Biol Chem       Date:  2002-01-09       Impact factor: 5.157

4.  Glial lipid droplets and ROS induced by mitochondrial defects promote neurodegeneration.

Authors:  Lucy Liu; Ke Zhang; Hector Sandoval; Shinya Yamamoto; Manish Jaiswal; Elisenda Sanz; Zhihong Li; Jessica Hui; Brett H Graham; Albert Quintana; Hugo J Bellen
Journal:  Cell       Date:  2015-01-15       Impact factor: 41.582

5.  The nuclear factor-erythroid 2-related factor/heme oxygenase-1 axis is critical for the inflammatory features of type 2 diabetes-associated osteoarthritis.

Authors:  Carlos Vaamonde-Garcia; Alice Courties; Audrey Pigenet; Marie-Charlotte Laiguillon; Alain Sautet; Xavier Houard; Saadia Kerdine-Römer; Rosa Meijide; Francis Berenbaum; Jérémie Sellam
Journal:  J Biol Chem       Date:  2017-07-06       Impact factor: 5.157

6.  The effect of extracorporeal shock waves on joint cartilage--an in vivo study in rabbits.

Authors:  N Väterlein; S Lüssenhop; M Hahn; G Delling; A L Meiss
Journal:  Arch Orthop Trauma Surg       Date:  2000       Impact factor: 3.067

7.  The effect of high-energy extracorporeal shock waves on hyaline cartilage of adult rats in vivo.

Authors:  Susanne Mayer-Wagner; Judith Ernst; Markus Maier; Matthias Chiquet; Helga Joos; Peter E Müller; Volkmar Jansson; Birte Sievers; Jörg Hausdorf
Journal:  J Orthop Res       Date:  2010-08       Impact factor: 3.494

8.  Oxidant conditioning protects cartilage from mechanically induced damage.

Authors:  Prem Ramakrishnan; Benjamin A Hecht; Douglas R Pedersen; Matthew R Lavery; Jerry Maynard; Joseph A Buckwalter; James A Martin
Journal:  J Orthop Res       Date:  2010-07       Impact factor: 3.494

9.  Mitogen-Activated Protein Kinases and Reactive Oxygen Species: How Can ROS Activate MAPK Pathways?

Authors:  Yong Son; Yong-Kwan Cheong; Nam-Ho Kim; Hun-Taeg Chung; Dae Gill Kang; Hyun-Ock Pae
Journal:  J Signal Transduct       Date:  2011-02-06

10.  Extracorporeal shockwave therapy in osteoporotic osteoarthritis of the knee in rats: an experiment in animals.

Authors:  Ching-Jen Wang; Chien-Yiu Huang; Shan-Ling Hsu; Jen-Hung Chen; Jai-Hong Cheng
Journal:  Arthritis Res Ther       Date:  2014-07-03       Impact factor: 5.156

View more
  2 in total

1.  Carnosine Alleviates Knee Osteoarthritis and Promotes Synoviocyte Protection via Activating the Nrf2/HO-1 Signaling Pathway: An In-Vivo and In-Vitro Study.

Authors:  Prabhakar Busa; Sing-Ong Lee; Niancih Huang; Yaswanth Kuthati; Chih-Shung Wong
Journal:  Antioxidants (Basel)       Date:  2022-06-20

2.  Zonal-Layered Chondrocyte Sheets for Repairment of Full-Thickness Articular Cartilage Defect: A Mini-Pig Model.

Authors:  Po-Chih Shen; Cheng-Chang Lu; Shih-Hsiang Chou; Zi-Miao Liu; Shu-Jem Su; Yin-Chun Tien
Journal:  Biomedicines       Date:  2021-11-30
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.